When was Maya Medical founded?

Maya Medical was founded in 2010 and raised its 1st funding round within a year of its incorporation.

Where is Maya Medical located?

Maya Medical is headquartered in Campbell, United States.

Is Maya Medical a funded company?

Maya Medical is a funded company, having raised a total of $6.92M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 23, 2010.

When was the latest funding round of Maya Medical?

Maya Medical's latest funding was a $***** Seed round on Apr 04, 2012, with participation from 0 investor. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $623M in funding in 2026 to date.

Where does Maya Medical rank among its competitors?

Maya Medical ranks 4th amongst 11 active competitors, of which 4 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Ablative Solutions, which secured $10.4M in Nov, 2025.

Who are the top competitors of Maya Medical?

Maya Medical's top competitors include ReCor Medical, Ablative Solutions and Autonomix. Among them, Ablative Solutions secured the most recent funding round in November, 2025.

Maya Medical - 2026 Company Profile, Funding & Competitors

Q: Is Maya Medical an acquired company?

Maya Medical got acquired by Covidien on May 08, 2012.

Maya Medical is an acquired company based in Campbell (United States), founded in 2010. It operates as a Catheter based ablative technology for renal denervation to treat hypertension. Maya Medical has raised $6.92M in funding. The company has 11 active competitors, including 4 funded and 5 that have exited. Its top competitors include companies like ReCor Medical, Ablative Solutions and Autonomix.

Company Details

Maya Medical is an early-stage company focused on the development of a novel percutaneous catheter for treatment of hypertension. Its product, The OneShot system, which won CE Mark in February 2012, is a balloon-based irrigated catheter technology for the treatment of hypertension. The product treats uncontrolled hypertension by ablating the renal sympathetic nerves in the outer wall of the renal arteries. It was acquired by Covidien, for $60M in cash, with the condition to make additional $170M if it met regulatory and sales milestones.

Key Metrics

Founded Year

2010

Location

Campbell, United States

Stage

Acquired

Total Funding

$6.92M in 4 rounds

Latest Funding Round

Seed, Apr 04, 2012, $*****

Investors

Shifamed & 1 more

Ranked

4^th among 11 active competitors

Similar Companies

ReCor Medical & 12 more

Exit Details

Acquired by Covidien (May 08, 2012)

View Maya Medical's full profile

Maya Medical is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MAYA MEDICAL INC CIN: 272917120 , United States, Active	Dec 31, 2009	-	-	-

Maya Medical got acquired by Covidien on May 08, 2012 at an acquisition amount of $*****.

Click here to take a look at Maya Medical's acquisition in detail

Maya Medical has raised a total funding of $6.92M over 4 rounds. Its first funding round was on Jul 23, 2010. Maya Medical has 2 institutional investors.

Here is the list of recent funding rounds of Maya Medical:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 04, 2012	8626252	Seed	1494848	1196661	5390589	5936280
Dec 30, 2011	6123083	Seed	2487750	9999374	1513135	1870203
Mar 11, 2011	7709546	Seed	5664305	3127320	6594101	1382029

Access funding benchmarks and valuations. Sign up today!

View details of Maya Medical's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Maya Medical include ReCor Medical, Ablative Solutions and Autonomix. Here is the list of Top 10 competitors of Maya Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ReCor Medical 2009, Palo Alto (United States), Acquired	Ultrasound-based renal denervation for hypertension treatment	$15M	Otsuka, WHE Investments & 2 others	60/100
2nd	Ablative Solutions 2011, Kalamazoo (United States), Series D	Developer of renal denervation for treatment of hypertension	$304M	BioStar Capital, Charter Capital Partners ... & 13 others	56/100
3rd	Autonomix 2014, The Woodlands (United States), Public	Developer of minimally invasive neural monitoring and treatment devices	$8.2M	-	54/100
4th	Maya Medical 2010, Campbell (United States), Acquired	Catheter based ablative technology for renal denervation to treat hypertension	$6.92M	Shifamed, Incept	42/100
5th	Kona Medical 2009, Issaquah (United States), Deadpooled	Ultrasound-based renal denervation to treat hypertension	$73.7M	Morningside, Saints Capital & 8 others	40/100
6th	Brattea 2013, Xuhui (China), Series D	Developer of a medical device for the treatment of hypertension	$15.2M	Zhongping Capital, Kuanping Capital & 9 others	34/100
7th	Vessix Vascular 2003, Laguna Hills (United States), Acquired	Thermoplasty technology directed towards patients with occlusive disease peripheral arteries and veins.	$27.7M	Orbimed, NeoMed & 4 others	32/100
8th	Kalos Medical 2015, Suwon-si (South Korea), Funding Raised	Developer of medical devices for the treatment of hypertension & other chronic diseases	-	Checkmate Capital, DSC Investment & 2 others	30/100
9th	Symple Surgical 2012, Menlo Park (United States), Series A	Medical device company developing microwave ablation technologies for chronic conditions	$3.4M	HHS, Moonshot	29/100
10th	Verve Medical 2011, Santa Barbara (United States), Seed	Provider of renal denervation for hypertension treatment	$3.63M	-	25/100